Citigroup’s Ambit Biosciences Corp AMBI Stock Holding History

Citigroup’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-367	Closed	-$6K	–	7633
2014 Q3	$6K	Buy	367 +70	+24%	+$481	﹤0.01%	6534
2014 Q2	$2K	Sell	297 -262	-47%	-$1.84K	﹤0.01%	6854
2014 Q1	$5K	Sell	559 -441	-44%	-$4.68K	﹤0.01%	6623
2013 Q4	$10K	Buy	+1,000	New	+$13.4K	﹤0.01%	6432
2013 Q3	–	Sell	-150	Closed	-$1K	–	7192
2013 Q2	$1K	Buy	+150	New	+$1.07K	﹤0.01%	6699

Citigroup's AMBI Position: Q4 2014 in Review

Citigroup sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 367 shares — an estimated $6K sold.

Citigroup first reported a position in AMBI in Q2 2013 and held it in 5 quarters. The position peaked at $10K in Q4 2013. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Citigroup reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Citigroup sold 367 Ambit Biosciences Corp shares in Q4 2014, an estimated $6K.
Citigroup first reported a position in Ambit Biosciences Corp in Q2 2013 and held it in 5 quarters.
Citigroup's Ambit Biosciences Corp position peaked at $10K in Q4 2013.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Citigroup's 13F filing for Q4 2014, filed 17 Feb 2015.